New study checks MS drug levels in breast milk

NCT ID NCT06143514

Recruiting now Knowledge-focused Sponsor: TG Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 31 times

Summary

This study looks at how much of the multiple sclerosis drug BRIUMVI passes into breast milk. About 16 women with relapsing MS who are already taking BRIUMVI and choose to breastfeed will provide milk samples. The goal is to measure drug levels, not to treat or cure the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

PROVIDE Virtual Research Coordination Center
RECRUITING

San Francisco, California, 94158, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
PROVIDE Virtual Research Coordination Center
RECRUITING

Smyrna, Georgia, 30080, United States
PROVIDE Virtual Research Coordination Center
RECRUITING

Wilmington, North Carolina, 28401-3331, United States
PROVIDE Virtual Research Coordination Center
RECRUITING

Nashville, Tennessee, 37215, United States
TG Therapeutics Investigational Trial Site
RECRUITING

Boston, Massachusetts, 02115, United States

Conditions

Explore the condition pages connected to this study.

RELAPSING MULTIPLE SCLEROSIS